An international team, headed by researchers at the University of California, San Diego School of Medicine, has identified a key enzyme in the reprogramming process that promotes malignant stem cell cloning and the growth of chronic myeloid leukemia , a cancer of the blood and marrow that experts say is increasing in prevalence.
http://www.eurekalert.org/pub_releases/2012-12/uoc--eam121912.php
http://www.eurekalert.org/pub_releases/2012-12/uoc--eam121912.php
No comments:
Post a Comment